Elliot C Woods, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycocalyx | 4 | 2018 | 88 | 1.370 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2017 | 137 | 0.570 |
Why?
|
| Cell Cycle | 1 | 2017 | 2967 | 0.340 |
Why?
|
| Polymers | 1 | 2015 | 1621 | 0.320 |
Why?
|
| Cell Survival | 2 | 2018 | 5882 | 0.280 |
Why?
|
| Integrins | 2 | 2018 | 846 | 0.220 |
Why?
|
| Neuraminidase | 2 | 2020 | 210 | 0.210 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10483 | 0.200 |
Why?
|
| Receptor, erbB-2 | 2 | 2020 | 2417 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 294 | 0.150 |
Why?
|
| Metalloendopeptidases | 1 | 2019 | 396 | 0.150 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 561 | 0.150 |
Why?
|
| Lectins | 1 | 2019 | 513 | 0.140 |
Why?
|
| Mucins | 1 | 2019 | 564 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1520 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 16690 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2020 | 1059 | 0.110 |
Why?
|
| Pyruvic Acid | 1 | 2014 | 200 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 424 | 0.110 |
Why?
|
| Mucin-1 | 1 | 2017 | 543 | 0.110 |
Why?
|
| Immunotherapy | 2 | 2020 | 4446 | 0.110 |
Why?
|
| Acidosis | 1 | 2014 | 270 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2019 | 1050 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2018 | 1423 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1376 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2016 | 1539 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2014 | 1132 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2019 | 4026 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2018 | 3749 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1632 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2019 | 4217 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3707 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 1387 | 0.070 |
Why?
|
| Leukocytes | 1 | 2013 | 2045 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 1736 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2013 | 1580 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2018 | 3481 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2725 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 2219 | 0.050 |
Why?
|
| Macrophages | 1 | 2016 | 5660 | 0.050 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2023 | 294 | 0.050 |
Why?
|
| Mice | 5 | 2020 | 81201 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2023 | 1588 | 0.040 |
Why?
|
| Killer Cells, Natural | 2 | 2020 | 2133 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2020 | 682 | 0.040 |
Why?
|
| Surface Tension | 1 | 2018 | 47 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18034 | 0.040 |
Why?
|
| Animals | 7 | 2020 | 168768 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 475 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2020 | 1247 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8861 | 0.040 |
Why?
|
| Protein Binding | 2 | 2020 | 9384 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 937 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2016 | 91 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2016 | 26 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2023 | 1357 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 479 | 0.030 |
Why?
|
| COS Cells | 1 | 2018 | 1161 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 21833 | 0.030 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2016 | 307 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2019 | 1802 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2018 | 627 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 491 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 744366 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2020 | 901 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2016 | 582 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 3689 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2204 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6313 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3554 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2018 | 19233 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5451 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2014 | 965 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 783 | 0.020 |
Why?
|
| Binding Sites | 1 | 2018 | 6111 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2725 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2016 | 3848 | 0.020 |
Why?
|
| Actins | 1 | 2016 | 2121 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 21696 | 0.020 |
Why?
|
| Metformin | 1 | 2014 | 836 | 0.020 |
Why?
|
| Kinetics | 1 | 2014 | 6476 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14561 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29060 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10183 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 2873 | 0.010 |
Why?
|
| Infant | 1 | 2023 | 35134 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5172 | 0.010 |
Why?
|
| Child | 1 | 2023 | 77709 | 0.010 |
Why?
|
| Female | 2 | 2018 | 380193 | 0.000 |
Why?
|
| Adult | 1 | 2018 | 214052 | 0.000 |
Why?
|
| Male | 1 | 2018 | 350115 | 0.000 |
Why?
|